HUP0102206A2 - Delavirdint tartalmazó tabletta formájú készítmény - Google Patents

Delavirdint tartalmazó tabletta formájú készítmény

Info

Publication number
HUP0102206A2
HUP0102206A2 HU0102206A HUP0102206A HUP0102206A2 HU P0102206 A2 HUP0102206 A2 HU P0102206A2 HU 0102206 A HU0102206 A HU 0102206A HU P0102206 A HUP0102206 A HU P0102206A HU P0102206 A2 HUP0102206 A2 HU P0102206A2
Authority
HU
Hungary
Prior art keywords
tablet formulation
delavirdine
superdisintegrant
binder
microcrystalline cellulose
Prior art date
Application number
HU0102206A
Other languages
English (en)
Inventor
Ashley H. Bates
E. John Lee
Alice C. Martino
Walter Morozowich
Original Assignee
Pharmacia & Upjohn Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22214517&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0102206(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Co. filed Critical Pharmacia & Upjohn Co.
Publication of HUP0102206A2 publication Critical patent/HUP0102206A2/hu
Publication of HUP0102206A3 publication Critical patent/HUP0102206A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

A találmány nem nyújtott felszabadulású gyógyászatitablettakészítményre vonatkozik, amely egy gyorsan kicsapódóhatóanyagot tartalmaz körülbelül 5% és körülbelül 60% közöttimennyiségben, mikrokristályos cellulóz és legalább egy kötőanyagottartalmaz körülbelül 2% és körülbelül 25% közötti mennyiségben, és egyszuperdiszintegránst körülbelül 6% és körülbelül 40% közöttimennyiségben, ahol a gyorsan kicsapódó hatóanyag, a mikrokristályoscellulóz, amelyben a kötőanyagot és a szuperdiszintegránst hevítés,oldószer és őrlés alkalmazása nélkül keverik össze és préseliktablettává. Ó
HU0102206A 1998-06-11 1999-06-07 Delavirdine tablet formulation HUP0102206A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8896098P 1998-06-11 1998-06-11
PCT/US1999/011798 WO1999063970A1 (en) 1998-06-11 1999-06-07 Delavirdine tablet formulation

Publications (2)

Publication Number Publication Date
HUP0102206A2 true HUP0102206A2 (hu) 2002-03-28
HUP0102206A3 HUP0102206A3 (en) 2002-12-28

Family

ID=22214517

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102206A HUP0102206A3 (en) 1998-06-11 1999-06-07 Delavirdine tablet formulation

Country Status (21)

Country Link
US (3) US6177101B1 (hu)
EP (1) EP1083885B1 (hu)
JP (1) JP4827296B2 (hu)
KR (2) KR100724016B1 (hu)
CN (1) CN1237958C (hu)
AT (1) ATE349203T1 (hu)
AU (1) AU753241C (hu)
BR (1) BR9910481A (hu)
CA (1) CA2328703C (hu)
CY (1) CY1105924T1 (hu)
DE (1) DE69934582T2 (hu)
DK (1) DK1083885T3 (hu)
EA (1) EA004311B1 (hu)
ES (1) ES2277682T3 (hu)
HK (1) HK1036417A1 (hu)
HU (1) HUP0102206A3 (hu)
NZ (1) NZ508762A (hu)
PL (1) PL200163B1 (hu)
PT (1) PT1083885E (hu)
WO (1) WO1999063970A1 (hu)
ZA (1) ZA200006090B (hu)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9910481A (pt) * 1998-06-11 2001-01-09 Upjohn Co Composição farmacêutica para comprimido de liberação não-contìnua
AP2002002552A0 (en) 1999-12-23 2002-06-30 Pfizer Prod Inc Pharmaceutical compositions providing enhanced drug concentrations.
US7115279B2 (en) 2000-08-03 2006-10-03 Curatolo William J Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
US20040243118A1 (en) * 2001-06-01 2004-12-02 Ayers Gregory M. Device and method for positioning a catheter tip for creating a cryogenic lesion
CA2458644A1 (en) * 2001-08-28 2003-03-13 Pharmacia Corporation Crystaline clindamycin free base
DE10164510A1 (de) * 2001-12-20 2003-07-10 Schering Ag Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes
JP2004107258A (ja) * 2002-09-18 2004-04-08 Ss Pharmaceut Co Ltd 催眠用圧縮成型製剤
WO2004066981A1 (en) * 2003-01-29 2004-08-12 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition containing metaxalone as active agent
CA2520321A1 (en) * 2003-04-04 2004-10-14 Pharmacia Corporation Oral extended release compressed tablets of multiparticulates
EP1635847B1 (en) 2003-06-13 2019-07-31 IDH Holding ApS Treatment of symptoms associated with bacterial vaginosis
MXPA06000178A (es) * 2003-07-01 2006-04-11 Pharmacia & Upjohn Co Llc Solidos modulados en la fase de difusion.
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050283146A1 (en) * 2004-06-17 2005-12-22 Lentz David J Thermally extended spiral cryotip for a cryoablation catheter
US20060099253A1 (en) * 2004-10-20 2006-05-11 Wyeth Antibiotic product formulation
US20070059359A1 (en) * 2005-06-07 2007-03-15 Thomas Backensfeld Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
WO2008012991A1 (fr) 2006-07-27 2008-01-31 Kabushiki Kaisha Kobe Seiko Sho Dispositif de connexion et installation de malaxage possédant un dispositif de malaxage et un dispositif d'entraînement connectés l'un à l'autre par le dispositif de connexion
CA2617688C (en) * 2007-02-22 2015-08-18 Alpex Pharma S.A. Solid dosage formulations containing weight-loss drugs
US8696606B2 (en) * 2009-09-28 2014-04-15 Continuous MotionFlow, LLC Passive motion machine with integrated mechanical DVT prophylactic therapy
WO2011041414A1 (en) 2009-09-30 2011-04-07 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
JP5226732B2 (ja) * 2010-05-20 2013-07-03 エスエス製薬株式会社 催眠用圧縮成型製剤
US20120010216A1 (en) * 2010-07-06 2012-01-12 Brown Arthur M Pharmaceutical compositions containing vanoxerine
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
CA2888883A1 (en) 2012-10-18 2014-04-24 Abbvie Inc. Formulations of pyrimidinedione derivative compounds
CN107595793B (zh) 2012-11-30 2020-11-13 阿库拉制药公司 活性药物成分的自调节释放
LT3007695T (lt) 2013-06-13 2024-03-25 Akebia Therapeutics, Inc. Kompozicijos ir būdai, skirti anemijos gydymui
EP3089757A1 (en) 2014-01-03 2016-11-09 AbbVie Inc. Solid antiviral dosage forms
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CA3097594A1 (en) * 2018-05-15 2019-11-21 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Pharmaceutical composition comprising small molecule egfr inhibitor and preparation method therefor
CN108619104A (zh) * 2018-06-29 2018-10-09 哈尔滨珍宝制药有限公司 一种基于盐酸克林霉素的药物组合物及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013785A (en) * 1975-03-21 1977-03-22 Bristol-Myers Company Apap tablet containing fumed silica and process for manufacturing same
ZA855250B (en) * 1984-08-17 1986-02-26 Upjohn Co Stable,high dose,high bulk density ibuprofen granulations for tablet and capsule manufacturing
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
DE3708916A1 (de) 1987-03-19 1988-09-29 Boehringer Ingelheim Kg Verfahren zur reinigung resorbierbarer polyester
US5211958A (en) * 1987-11-30 1993-05-18 Gist-Brocades, N.V. Pharmaceutical composition and process for its preparation
ES2047540T3 (es) * 1987-11-30 1994-03-01 Brocades Pharma Bv Compuesto farmaceutico y procedimiento para su preparacion.
US5256699A (en) * 1988-10-18 1993-10-26 Ciba-Geify Corporation Dispersible tablet formulation of diclofenac acid free base
GB8824392D0 (en) * 1988-10-18 1988-11-23 Ciba Geigy Ag Dispersible formulation
CA2007764C (en) 1989-02-24 1999-11-30 Joseph Michael Beaurline Salsalate tablet
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
CA2031803C (en) 1989-12-13 2001-05-29 Ramakrishnan Nagarajan Improvements in or relating to glycopeptide deriveratives
US5563142A (en) * 1989-12-28 1996-10-08 The Upjohn Company Diaromatic substituted compounds as anti-HIV-1 agents
US5519021A (en) * 1992-08-07 1996-05-21 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
US5358941A (en) 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
FR2711524B1 (fr) * 1993-10-21 1995-11-24 Rhone Dpc Europ Procédé de préparation de compositions orales contenant des quinolones.
MX9604831A (es) 1994-04-15 1998-05-31 Upjohn Co Formas nuevas de cristal de 1-[5-metanosulfonamidoindolil-2-carbonil]-4-[3-(1-metiletila mino)-2-piridinil]-piperazina.
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
UA72207C2 (uk) * 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення
BR9910481A (pt) * 1998-06-11 2001-01-09 Upjohn Co Composição farmacêutica para comprimido de liberação não-contìnua

Also Published As

Publication number Publication date
CA2328703C (en) 2007-10-30
EP1083885A1 (en) 2001-03-21
JP4827296B2 (ja) 2011-11-30
KR100724016B1 (ko) 2007-05-31
KR20010052717A (ko) 2001-06-25
CN1301149A (zh) 2001-06-27
KR20070040426A (ko) 2007-04-16
CA2328703A1 (en) 1999-12-16
CY1105924T1 (el) 2011-04-06
HUP0102206A3 (en) 2002-12-28
AU753241B2 (en) 2002-10-10
BR9910481A (pt) 2001-01-09
ATE349203T1 (de) 2007-01-15
EA004311B1 (ru) 2004-02-26
EA200100024A1 (ru) 2001-06-25
PL200163B1 (pl) 2008-12-31
HK1036417A1 (en) 2002-01-04
AU4213499A (en) 1999-12-30
US6177101B1 (en) 2001-01-23
ES2277682T3 (es) 2007-07-16
PL344328A1 (en) 2001-10-22
DK1083885T3 (da) 2007-02-26
ZA200006090B (en) 2001-10-29
WO1999063970A1 (en) 1999-12-16
DE69934582T2 (de) 2007-10-04
PT1083885E (pt) 2007-01-31
AU753241C (en) 2003-05-08
US7108864B1 (en) 2006-09-19
CN1237958C (zh) 2006-01-25
DE69934582D1 (de) 2007-02-08
JP2002517430A (ja) 2002-06-18
US20060257476A1 (en) 2006-11-16
NZ508762A (en) 2003-07-25
EP1083885B1 (en) 2006-12-27

Similar Documents

Publication Publication Date Title
HUP0102206A2 (hu) Delavirdint tartalmazó tabletta formájú készítmény
HK1046244A1 (en) Controlled release and taste masking oral pharmaceutical compositions.
MY125766A (en) Flash-melt oral dosage formulation
BR9908438A (pt) Tabletes de desintegração rápida
HUP0500509A2 (hu) Azonnali felszabadulást biztosító mikronizált gyógyászati és gyógytáp porok
GEP20053420B (en) Sustained Release Ranolanolazine Formulation
HUP0100072A3 (en) Phenoxazine, phenthiazine derivatives, their use in medicine; process for their preparation and pharmaceutical compositions containing them
BR9912979B1 (pt) composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan.
AU3080895A (en) Novel piperazides derived from arylpiperazine, processes for their preparation, their use as medicaments and pharmaceutical compositions comprising them
HUP0103883A2 (hu) Új, késleltetett felszabadulású, orális készítmények
HUP0202497A2 (hu) Orális, hidrodinamikailag szabályozott hatóanyag leadású készítmény
MY127350A (en) Flash-melt oral dose formulations
HUP0004966A2 (en) Pharmaceutical composition for oral administration in the form of matrix tablet enabling the prolonged release of trimetazidine
HUP9900154A2 (hu) Trovafloxacin-mezilát tabletta
ZA200108001B (en) Processes for making pharmaceutical oral ECB formulations and compositions.
MXPA04003346A (es) Formulacion de dosis oral de disolucion instantanea.
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
IL136142A0 (en) High drug load immediate and modified release oral dosage formulations and processes for their manufacture
DE60108354D1 (de) 2H-1-Benzopyran-Derivative, Prozesse zu ihrer Herstellung und Pharmazeutische Zusammensetzungen
ZA200110073B (en) 14β-H-Sterols, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments.
HUP0200208A3 (en) L-arabino-disaccharides of anthracyclines, processes for their preparation, and pharmaceutical compositions containing them and their use
YU28404A (sh) Brzo topljiva formulacija za oralno doziranje

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished